Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Ascentage Pharma Group: Clinical Trials & FDA Approval Profile

Ascentage Pharma Group (Global / Institutional) sponsors 29 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 15 active protocols (14 recruiting now), 1 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)17.2%
Median Closed Enrollment vs National (145 pts)34 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Ascentage Pharma Group
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)29
Active Pipeline (Recruiting Now)15 (14)
Completed vs Stopped Early1 / 5 (17.2%)
Median Closed Actual Enrollment34 participants
Physical Hospital Site Disclosure28.1% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Ascentage Pharma Group
Hospital Research SiteLocationShared Protocols
Sun Yat-sen University Cancer CenterGuangzhou, Guangdong11
Nanfang Hospital of Southern Medical UniversityGuangzhou, Guangdong6
MD Anderson Cancer CenterHouston, TX5

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Ascentage Pharma Group
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06319456A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.Phase IIIRECRUITING
NCT04126681A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic PhasePhase IICOMPLETED

Explore interactive annual charts and M&A subsidiary rollups in the Ascentage Pharma Group Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI